Ketovision

Ketorolac Trometamol, the active ingredient in Ketovision, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an ophthalmic solution for ocular use. It reduces postoperative ocular inflammation and pain in patients following eye surgery. The formulation is designed for topical instillation into the conjunctival sac, providing rapid onset of anti‑inflammatory effect.

GNH USA supplies Ketovision as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide across multiple regions.

Ketovision, a topical NSAID, acts on ocular inflammatory pathways to manage postoperative and other inflammatory eye conditions.

- Post‑operative ocular inflammation: reduces swelling and redness after eye surgery. - Ocular pain following eye surgery: alleviates discomfort and burning sensations. - Inflammatory eye conditions: controls inflammation in conditions such as uveitis or iritis.

Ketovision may cause ocular and systemic reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Transient blurred vision. - Conjunctival hyperemia (redness). - Itching or mild irritation. - Excessive tearing. - Foreign‑body sensation.

Serious or Rare Side Effects: - Corneal ulceration or epithelial defects. - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Increased intra‑ocular pressure. - Persistent or worsening pain. - Vision loss. - Secondary infection of the eye.

When using Ketovision, consider the following precautions: - Assess for hypersensitivity: avoid use in patients with known ketorolac or NSAID allergy. - Monitor intra‑ocular pressure: use caution in patients with glaucoma. - Avoid concurrent ocular infections: ensure infection is treated before administration. - Use only as prescribed: do not exceed the recommended frequency or duration. - Store at room temperature: keep in the original container, protect from light and moisture.

Ketovision may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use of other ophthalmic NSAIDs: increased risk of corneal toxicity. - Systemic NSAIDs: additive systemic exposure may raise bleeding risk.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Anticholinergic eye drops: may reduce drug absorption. - Contact lens wear: may affect drug distribution and comfort.